Pretreatment with inhaled procaterol improves symptoms of dyspnea and quality of life in patients with severe COPD

BACKGROUND: The clinical efficacy of short-acting β(2)-agonists administered before performing daily activities in chronic obstructive pulmonary disease (COPD) is unclear. The aim of this study was to investigate the clinical effect of supplementary inhaled procaterol hydrochloride in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohbayashi, Hiroyuki, Adachi, Mitsuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396116/
https://www.ncbi.nlm.nih.gov/pubmed/22807639
http://dx.doi.org/10.2147/IJGM.S20833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396116/
https://www.ncbi.nlm.nih.gov/pubmed/22807639
http://dx.doi.org/10.2147/IJGM.S20833

Ejemplares similares